Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening

Cancer

Volumn 121, Issue 24, 2015, Pages 4341-4347

  Howard, David H ^a   Richards, Thomas B ^b   Bach, Peter B ^c   Kegler, Michelle C ^a   Berg, Carla J ^a  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

comorbidity; early detection of cancer; life expectancy; lung neoplasms; population characteristics; smoking

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SCREENING; COMORBIDITY; EARLY DIAGNOSIS; FEMALE; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SMOKING; UNITED STATES; DIABETES MELLITUS; EARLY CANCER DIAGNOSIS; HEART DISEASES; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MEDICARE; MIDDLE AGED; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; EARLY DETECTION OF CANCER; FEMALE; HEART DISEASES; HUMANS; KAPLAN-MEIER ESTIMATE; LIFE EXPECTANCY; LUNG NEOPLASMS; MALE; MEDICARE; MIDDLE AGED; SMOKING; STROKE; UNITED STATES;

EID: 84949316611     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29677     Document Type: Article

References (29)

1. Moyer VA,; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160: 330-338.
2. Syrek JT, Chin J, Ashby L, Hermansen J, Hutter L,; Center for Medicare & Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed February 11, 2015.
3. National Lung Screening Trial Research Team, Aberle DR, Berg CD, et al., The National Lung Screening Trial: overview and study design. Radiology. 2011; 258: 243-253.
4. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al., Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Cancer Inst. 2010; 102: 1771-1779.
5. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al., Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
6. Pinsky PF, Gierada DS, Hocking W, Patz EF Jr, Kramer BS,. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med. 2014; 161: 627-633.
7. Jamal A, Agaku IT, O'Connor E, King BA, Kenemer JB, Neff L,. Current cigarette smoking among adults-United States, 2005-2013. MMWR Morb Mortal Wkly Rep. 2014; 63: 1108-1112.
8. Werner CA,. The Older Population: 2010. Census Brief C2010BR-09. Washington, DC: US Census Bureau; 2011.
9. Pinsky PF, Berg CD,. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? J Med Screen. 2012; 19: 154-156.
10. Doria-Rose VP, White MC, Klabunde CN, et al., Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012; 21: 1049-1059.
11. Ma J, Ward EM, Smith R, Jemal A,. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013; 119: 1381-1385.
12. Institute for Social Research. The Health and Retirement Study: an introduction. http://hrsonline.isr.umich.edu/index.php?p=intro. Accessed December 10, 2014.
13. National Cancer Institute Cancer Data Access System. National Lung Screening Trial. https://biometry.nci.nih.gov/cdas/studies/nlst/. Access March 2, 2015.
14. Arias E,. United States life tables, 2006. Natl Vital Stat Rep. 2010; 58: 1-40.
15. Howard DH, Tangka FK, Seeff LC, Richardson LC, Ekwueme DU,. The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer. Health Econ. 2009; 18: 1381-1393.
16. Bach PB, Mirkin JN, Oliver TK, et al., Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307: 2418-2429.
17. Bach PB, Gould MK,. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012; 157: 571-573.
18. de Koning HJ, Meza R, Plevritis SK, et al., Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force. Ann Intern Med. 2014; 160: 311-320.
19. Patz EF Jr, Pinsky P, Gatsonis C, et al,; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174: 269-274.
20. Smieliauskas F, MacMahon H, Salgia R, Shih YC,. Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening. J Med Screen. 2014; 21: 207-215.
21. Eberth JM, Qiu R, Adams SA, et al., Lung cancer screening using low-dose CT: the current national landscape. Lung Cancer. 2014; 85: 379-384.
22. McMahon PM, Kong CY, Bouzan C, et al., Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011; 6: 1841-1848.
23. Agency for Healthcare Research and Quality. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2015.
24. Pua BB, Dou E, O'Connor K, Crawford CB,. Integrating smoking cessation into lung cancer screening programs [published online ahead of print May 16, 2015]. Clin Imaging pii: S0899-707100116-3. doi: 10.1016/j.clinimag.2015.05.004.
25. Centers for Disease Control and Prevention (CDC). Quitting smoking among adults-United States, 2001-2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1513-1519.
26. Park ER, Gareen IF, Japuntich S, et al., Primary care provider-delivered smoking cessation interventions and smoking cessation among participants in the National Lung Screening Trial [published online ahead of print June 15, 2015]. JAMA Intern Med. doi: 10.1001/jamainternmed.2015.2391.
27. Memorial Sloan Kettering Cancer Center. Lung Cancer Screening Decision Tool. http://nomograms.mskcc.org/Lung/Screening.aspx. Accessed December 2, 2014.
28. US Department of Veterans Affairs, National Center for Health Promotion and Disease Prevention. Lung cancer screening. http://www.prevention.va.gov/Lung-Cancer-Screening.asp. Accessed March 10, 2015.
29. Volk RJ, Linder SK, Leal VB, et al., Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prev Med. 2014; 62: 60-63.